Abstract
The history of fragment-based drug discovery, with an emphasis on crystallographic methods, is sketched, illuminating various contributions, including our own, which preceded the industrial development of the method. Subsequently, the creation of the BMSC fragment cocktails library is described. The BMSC collection currently comprises 68 cocktails of 10 compounds that are shape-wise diverse. The utility of these cocktails for initiating lead discovery in structure-based drug design has been explored by soaking numerous protein crystals obtained by our MSGPP (Medical Structural Genomics of Pathogenic Protozoa) consortium. Details of the fragment selection and cocktail design procedures, as well as examples of the successes obtained are given. The BMSC Fragment Cocktail recipes are available free of charge and are in use in over 20 academic labs.
Keywords: Structural genomics, drug design, malaria, trypanosomiasis, leishmaniasis, history
Current Topics in Medicinal Chemistry
Title: Fragment-Based Cocktail Crystallography by the Medical Structural Genomics of Pathogenic Protozoa Consortium
Volume: 9 Issue: 18
Author(s): Jonathan M. Caruthers, Wim G.J. Hol, Ethan A. Merritt, Frederick S. Buckner, Wesley C. Van Voorhis, Frank Zucker, Natasha Mueller, Angela Kelley, Alberto Napuli, Isolde LeTrong, Eric T. Larson, Christophe L.M.J. Verlinde, Jurgen Bosch, Tracy L. Arakaki, Liren Xiao, Jessica Kim, Jennifer Ross, Wei Deng, Zhihua Sun, Zhongsheng Zhang, Sayaka Shibata and Erkang Fan
Affiliation:
Keywords: Structural genomics, drug design, malaria, trypanosomiasis, leishmaniasis, history
Abstract: The history of fragment-based drug discovery, with an emphasis on crystallographic methods, is sketched, illuminating various contributions, including our own, which preceded the industrial development of the method. Subsequently, the creation of the BMSC fragment cocktails library is described. The BMSC collection currently comprises 68 cocktails of 10 compounds that are shape-wise diverse. The utility of these cocktails for initiating lead discovery in structure-based drug design has been explored by soaking numerous protein crystals obtained by our MSGPP (Medical Structural Genomics of Pathogenic Protozoa) consortium. Details of the fragment selection and cocktail design procedures, as well as examples of the successes obtained are given. The BMSC Fragment Cocktail recipes are available free of charge and are in use in over 20 academic labs.
Export Options
About this article
Cite this article as:
Caruthers M. Jonathan, Hol G.J. Wim, Merritt A. Ethan, Buckner S. Frederick, Van Voorhis C. Wesley, Zucker Frank, Mueller Natasha, Kelley Angela, Napuli Alberto, LeTrong Isolde, Larson T. Eric, Verlinde L.M.J. Christophe, Bosch Jurgen, Arakaki L. Tracy, Xiao Liren, Kim Jessica, Ross Jennifer, Deng Wei, Sun Zhihua, Zhang Zhongsheng, Shibata Sayaka and Fan Erkang, Fragment-Based Cocktail Crystallography by the Medical Structural Genomics of Pathogenic Protozoa Consortium, Current Topics in Medicinal Chemistry 2009; 9 (18) . https://dx.doi.org/10.2174/156802609790102383
DOI https://dx.doi.org/10.2174/156802609790102383 |
Print ISSN 1568-0266 |
Publisher Name Bentham Science Publisher |
Online ISSN 1873-4294 |
Call for Papers in Thematic Issues
Chemistry Based on Natural Products for Therapeutic Purposes
The development of new pharmaceuticals for a wide range of medical conditions has long relied on the identification of promising natural products (NPs). There are over sixty percent of cancer, infectious illness, and CNS disease medications that include an NP pharmacophore, according to the Food and Drug Administration. Since NP ...read more
Current Trends in Drug Discovery Based on Artificial Intelligence and Computer-Aided Drug Design
Drug development discovery has faced several challenges over the years. In fact, the evolution of classical approaches to modern methods using computational methods, or Computer-Aided Drug Design (CADD), has shown promising and essential results in any drug discovery campaign. Among these methods, molecular docking is one of the most notable ...read more
Drug Discovery in the Age of Artificial Intelligence
In the age of artificial intelligence (AI), we have witnessed a significant boom in AI techniques for drug discovery. AI techniques are increasingly integrated and accelerating the drug discovery process. These developments have not only attracted the attention of academia and industry but also raised important questions regarding the selection ...read more
From Biodiversity to Chemical Diversity: Focus of Flavonoids
Flavonoids are the largest group of polyphenols, plant secondary metabolites arising from the essential aromatic amino acid phenylalanine (or more rarely from tyrosine) via the phenylpropanoid pathway. The flavan nucleus is the basic 15-carbon skeleton of flavonoids (C6-C3-C6), which consists of two phenyl rings (A and B) and a heterocyclic ...read more
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Anti-Angiogenic Therapy as a Cancer Treatment Paradigm
Current Medicinal Chemistry - Anti-Cancer Agents Current Strategies for Probing Substrate Specificity of Proteases
Current Medicinal Chemistry Ezetimibe and other Azetidinone Cholesterol Absorption Inhibitors
Current Topics in Medicinal Chemistry Repurposing Metformin for Vascular Disease
Current Medicinal Chemistry Pathophysiology of Airway Colonization in Critically ill COPD Patient
Current Drug Targets The Morita-Baylis-Hillman Reaction: Advances and Contributions from Brazilian Chemistry
Current Organic Synthesis Prodigiosins as Anti Cancer Agents: Living Upto Their Name
Current Pharmaceutical Design Pharmacological Perspectives of Ayurvedic Herbs <i>viz. Alstonia scholaris</i> L., <i>Picrorhiza kurroa, Swertia chirata</i> and <i>Caesalpinia crista</i> Against COVID- 19: A Mini-Review
Mini-Reviews in Organic Chemistry Computational and Molecular Docking Studies of New Benzene Sulfonamide Drugs with Anticancer and Antioxidant Effects
Current Organic Synthesis Clinical Aspects of Melatonin in the Acute Coronary Syndrome
Current Vascular Pharmacology Mechanistic Aspects of Medicinal Plants and Secondary Metabolites against Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2)
Current Pharmaceutical Design Impact of COVID-19 Infection on Maternal and Neonatal Outcomes: A Review of 11078 Pregnancies Reported in the Literature
Current Women`s Health Reviews A Technological Update of Molecular Diagnostics for Infectious Diseases
Infectious Disorders - Drug Targets Biology and Clinical Relevance of Mannose-Binding Lectin
Drug Design Reviews - Online (Discontinued) Targeting Monoamine Oxidases with Multipotent Ligands: An Emerging Strategy in the Search of New Drugs Against Neurodegenerative Diseases
Current Medicinal Chemistry Isolation, Structural Determination, and Evaluation of the Biological Activity of 20(S)-25-methoxyl-dammarane-3β, 12β, 20-triol [20(S)-25-OCH3-PPD], a Novel Natural Product from Panax notoginseng
Medicinal Chemistry Artificial Intelligence and Cheminformatics-Guided Modern Privileged Scaffold Research
Current Topics in Medicinal Chemistry Epidemiology and Clinical Presentation of Stress-Related Peptic Damage and Chronic Peptic Ulcer
Current Molecular Medicine The Role and Significance of Unconventional Hydrogen Bonds in Small Molecule Recognition by Biological Receptors of Pharmaceutical Relevance
Current Pharmaceutical Design Recent Progress in Anticonvulsant Drug Research: Strategies for Anticonvulsant Drug Development and Applications of Antiepileptic Drugs for Non-Epileptic Central Nervous System Disorders
Current Topics in Medicinal Chemistry